EaseValueWhat Happened?
On October 1, 2026, the Reserve Bank of India issued the Reserve Bank of India (Local Area Banks - Acquisition and Holding of Shares or Voting Rights) Amendment Directions, 2026. This is a major regulatory change that relaxes shareholding acquisition rules for three categories of financial institutions: mutual funds, insurance companies, and pension funds. Previously, these entities needed fresh prior RBI approval each time they acquired major shareholding in a banking company. Now, they can obtain one-time approval for subsequent major shareholding acquisitions up to 10% of paid-up share capital or voting rights in the same Local Area Bank (LAB).
Background & Legal Context
The original Master Direction on Local Area Banks - Acquisition and Holding of Shares or Voting Rights was issued on November 28, 2025, under Sections 12, 12B, and 35A of the Banking Regulation Act, 1949. That direction mandated mandatory prior RBI approval for any person seeking initial acquisition of major shareholding in a banking company.
Key definitions introduced in the amended directions:
- Qualifying Person: Must be either a mutual fund (registered with SEBI), pension fund (registered with PFRDA), or insurance company (registered with IRDAI) that does not belong to the promoter group of the investee banking company.
- Qualifying Person with One-Time Approval: A qualifying person that has obtained one-time approval but does not hold major shareholding at a particular point in time.
- Major Shareholding: Aggregate shareholding of 10% or more of paid-up share capital or voting rights.
The amendment also clarifies that when a portfolio manager advises a client on share acquisition, the client (not the portfolio manager) is considered the direct acquirer if:
- The client is the registered owner and entitled to exercise voting rights
- The portfolio manager provides only non-binding advisory services
- Voting rights are exercised based on specific client mandate
Important Tax and Compliance Angle: Under the Income Tax Act 2025, shareholding patterns and acquisition of shares trigger several tax implications including capital gains tax, securities transaction tax (STT), and dividend income taxation. For AY 2026-27, any acquisition of major shareholding must be reported in the Income Tax return under Schedule FA (financial assets).
What Does This Mean for You?
For Mutual Funds:
If you manage a mutual fund registered with SEBI and want to increase holdings in a Local Area Bank, you now have significantly reduced compliance burden. Instead of filing a fresh RBI application every time you cross the 5% threshold, you can obtain one-time blanket approval for acquisitions up to 10%. This is especially beneficial for large fund houses with multiple schemes investing in LABs.
For Insurance Companies:
Insurance companies, including life and general insurers registered with IRDAI, can now acquire major shareholding in LABs more efficiently. This opens opportunities for strategic investments in banking companies. However, you must ensure your investment committee approves the acquisition strategy as per IRDAI guidelines, and comply with statutory investment limits under the Insurance Act.
For Pension Funds:
Pension funds registered with the Pension Fund Regulatory and Development Authority (PFRDA) can now pursue strategic shareholding in LABs without repeated regulatory approvals. This is beneficial for long-term portfolio management as required under pension fund governance.
Important Condition - Promoter Group Exclusion:
If your organization belongs to the promoter group of the LAB in question, you cannot use this one-time approval mechanism. Instead, you must follow the traditional prior approval route. Additionally, if the LAB is part of your group, the bank itself can file the application on your behalf.
Tax Reporting Requirements:
- For AY 2026-27, report the acquisition in Schedule FA of your Income Tax return
- Capital gains arising from subsequent sale of these shares will be taxable under Section 48 of the Income Tax Act 2025 (short-term if held less than 12 months, long-term if held more)
- Dividend income from LAB shares is taxable under Section 56 as per your tax slab
- STT liability arises on acquisition and sale of shares traded on recognized exchanges
Continuous Monitoring & Reporting Obligations:
Once you acquire major shareholding (10% or more), you must report to RBI and the LAB within three working days if your aggregate holding increases above or decreases below 5% of total paid-up share capital. This is a strict compliance requirement with potential penalties for non-compliance.
Form Requirements:
Applications must be submitted through PRAVAAH (RBI's online portal) along with Form A declaration. The LAB itself must provide comments in Form A1. Ensure your documentation is complete as incomplete applications cause delays.
What Should You Do Now?
Immediate Actions:
- Review your current shareholdings: Check if you hold shares in any Local Area Banks and whether you are classified as a qualifying person. If you previously required multiple approvals, you now qualify for one-time approval.
- Assess your investment strategy: With this new mechanism in place, evaluate whether increasing your LAB shareholding up to 10% aligns with your portfolio objectives. This is particularly relevant for AY 2026-27 planning.
- Prepare RBI application: If you wish to avail one-time approval, prepare your PRAVAAH application immediately. Engage your compliance team and ensure all required documents are ready.
- Coordinate with the LAB: Contact the LAB's governance team to ensure they submit Form A1 comments simultaneously with your application for faster approval.
- Update tax records: Inform your tax and accounts team about this strategic acquisition so they can properly classify and track the investment for ITR filing.
- Establish monitoring mechanism: Create an internal system to track your shareholding and trigger alerts when you approach or cross 5% threshold to ensure timely reporting to RBI.
Long-term Compliance Setup:
- Implement quarterly shareholding tracking to avoid missing reporting deadlines
- Maintain detailed acquisition records with dates, quantities, and costs for capital gains calculation
- Create a compliance calendar flagging the three-working-day reporting requirement
- Ensure your fit-and-proper status is maintained as RBI can revoke approval if you become non-compliant
Key Takeaways
- Regulatory Relief: Mutual funds, insurance companies, and pension funds no longer need fresh RBI approval for each major shareholding acquisition in the same LAB - one-time approval covers up to 10% aggregate holding.
- Strategic Opportunity: This amendment opens doors for long-term strategic investments in LABs by institutional investors, making banking sector investments more accessible for pension and insurance portfolios.
- Promoter Group Restriction: This facility is NOT available if your organization belongs to the LAB's promoter group - you must follow traditional approval routes instead.
- Tax Compliance Critical: While regulatory burden reduces, tax compliance increases - you must report acquisitions in ITR Schedule FA, track capital gains, and monitor STT liability for AY 2026-27 and onwards.
- Three-Day Reporting Deadline: Do not miss the three-working-day reporting requirement when your shareholding crosses 5% threshold - this is strict and violations attract RBI penalties.
Need expert help with this? EaseValue CAs in Jaipur — WhatsApp 63677 44602